MARKET

OCGN

OCGN

Ocugen Inc
NASDAQ
1.390
0.000
0.00%
After Hours: 1.380 -0.01 -0.72% 17:18 08/21 EDT
OPEN
1.410
PREV CLOSE
1.390
HIGH
1.420
LOW
1.370
VOLUME
2.43M
TURNOVER
--
52 WEEK HIGH
2.725
52 WEEK LOW
0.9800
MARKET CAP
471.36M
P/E (TTM)
-5.4574
1D
5D
1M
3M
1Y
5Y
1D
Ocugen’s Earnings Call Highlights Risk-Reward Inflection
TipRanks · 1d ago
Ocugen Inc. Stock Rises 10.4%, Outperforms Market
Dow Jones · 2d ago
Ocugen’s Phase 3 Gene Therapy Trial Targets High-Value Dry AMD Market
TipRanks · 2d ago
Weekly Report: what happened at OCGN last week (0810-0814)?
Weekly Report · 4d ago
Ocugen Targets 2027 BLA Filings as Gene Therapy Programs Near Key Readouts
NASDAQ · 6d ago
Ocugen Inc. Stock Advances 4.6%, Outperforms Market
Dow Jones · 08/11 20:34
Weekly Report: what happened at OCGN last week (0803-0807)?
Weekly Report · 08/10 09:34
Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Ocugen (OCGN)
TipRanks · 08/10 08:20
More
About OCGN
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Novel Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.

Webull offers Ocugen Inc stock information, including NASDAQ: OCGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCGN stock methods without spending real money on the virtual paper trading platform.